NLRP3 and pemphigus foliaceus: Therefore, identifying critical components of the inflammasome complex and its downstream effectors, such as NALP3, ASC, IL-1β, and IL-18, may be key for developing potential therapeutic targets, which will be important for novel PF treatments in the future.